International Myeloma Foundation Honors Dr. S. Vincent Rajkumar
With the 2016 Robert A. Kyle Lifetime Achievement Award
Given in Recognition of Significant Contributions to Myeloma Research and Patient Care
North Hollywood, CA, May 31, 2016—The International Myeloma Foundation (IMF) — improving the quality of life of myeloma patients while working toward prevention and a cure — will present the 14th annual Robert A. Kyle Lifetime Achievement Award to Dr. S. Vincent Rajkumar during a ceremony in Copenhagen, Denmark on June 8, 2016.
Since 2003, the IMF has honored an outstanding physician annually with the award, which is named for its first recipient, the world-renowned myeloma expert Dr. Robert Kyle. The 14th Kyle Lifetime Achievement Award ceremony will be held during the IMF’s annual International Myeloma Working Group (IMWG) Summit in Copenhagen.
“We applaud Dr. Rajkumar’s accomplishments and important contributions to improving the lives of myeloma patients,” said IMF President Susie Novis Durie. Kyle Award honorees are individuals whose work in the field of myeloma has resulted in significant advances in research, treatment and care of myeloma patients.
“Dr. Rajkumar’s work perfectly reflects the words of Dr. William Mayo, founder of the Mayo Clinic, who challenged the nature of patient care nearly a century ago when he said ‘The needs of the patient are the only needs to be considered.’ And, as Vincent would add, both now and for the future,” said IMF Chairman Dr. Brian Durie.
Dr. Rajkumar, the Edward W. and Betty Knight Scripps Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, has worked closely with Dr. Kyle for 20 years. “Bob Kyle is an inspiration—the person I want to be like, but simply cannot,” said Dr. Rajkumar. The award, he added, is “a reflection of Dr. Kyle’s leadership, vision, and guidance, more than anything I have done. The people who have won this award in the past are giants in the field, and I am very humbled.”
In 1995, Dr. Rajkumar joined Mayo Clinic to train in hematology and medical oncology. He joined the staff in 1999, rising to professor in 2006. His research focuses on clinical, epidemiological, and laboratory research for myeloma and related disorders.
Dr. Rajkumar has led numerous phase I, II, and III clinical trials investigating the role of new agents in myeloma, including the pivotal trials that led to the approval of thalidomide in myeloma in the US, and has published more than 300 peer-reviewed papers primarily in the field of myeloma and related plasma cell disorders. Dr. Rajkumar was lead author on the 2014 IMWG Updated Criteria for the Diagnosis of Multiple Myeloma, considered to be a paradigm shift in the approach to multiple myeloma.
In addition to his stellar research credentials, Dr. Rajkumar excels at science communications, serving as Associate Editor for the Mayo Clinic Proceedings; Section Editor for the journal Leukemia; Associate Editor for the European Journal of Haematology; and Editor-in-Chief of Blood Cancer Journal. He is equally adept at sharing medical information through social media, as his thousands of Twitter followers can attest.
Receiving the Kyle Award, said Dr. Rajkumar, “is the highest honor possible for me and I am thankful to the IMF, the IMWG, and my colleagues from around the world.”
ABOUT THE INTERNATIONAL MYELOMA FOUNDATION
Celebrating its 25th anniversary, the International Myeloma Foundation (IMF) is the oldest and largest foundation focusing specifically on multiple myeloma. The Foundation’s reach extends to more than 400,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure by focusing on four key areas: research, education, support, and advocacy. The IMF has conducted more than 250 educational seminars worldwide, maintains a world-renowned InfoLine, and in 2001, established the International Myeloma Working Group (IMWG), a collaborative research initiative focused on improving myeloma treatment options for patients. In 2013, the IMF launched the Black Swan Research Initiative®, a groundbreaking research project aimed at curing myeloma. The IMF can be reached at (800) 452-CURE (2873). The global website is www.myeloma.org. Follow the IMF on Twitter @IMFmyeloma.